| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |